By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems today reported that its fourth-quarter revenues more than tripled on sales of its SmartChip products.

The Fremont, Calif.-based firm brought in total revenues of $712,369 for the three-month period ended Dec. 31, compared to $189,757 for the fourth quarter of 2009. The increase was driven by sales of its SmartChip Real-Time PCR System, which was launched in August 2010, and associated consumables and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.